URGN – urogen pharma ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Why The UroGen Pharma (URGN) Investment Story Is Shifting As Analysts Hold Fair Value Steady [Yahoo! Finance]
Urogen Pharma (URGN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $33.00 price target on the stock.
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
UroGen Applauds BCAN's New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence [Yahoo! Finance]
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
Form 10-K UroGen Pharma Ltd. For: Dec 31
Form 8-K UroGen Pharma Ltd. For: Mar 02
Form 8-K UroGen Pharma Ltd. For: Feb 26
Form 4 UroGen Pharma Ltd. For: Feb 26 Filed by: Robinson James A. Jr.
Form 4 UroGen Pharma Ltd. For: Jan 31 Filed by: Barrett Elizabeth A.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.